Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Jeremy Farrar, Director of the Wellcome Trust in the UK, led a review panel team to Nairobi and Kilifi in Kenya last week, to assess projects that had been ongoing over the past five years. The structural and project assessment review was conducted on Monday through to Wednesday.

CTMGH logo for News

Professor Jeremy Farrar, Director of the Wellcome Trust in the UK, led a review panel team to Nairobi and Kilifi in Kenya last week, to assess projects that had been ongoing over the past five years. The structural and project assessment review was conducted on Monday through to Wednesday.
KEMRI-Wellcome Trust in Kenya, has had high-impact research projects over the past 20 years and achieved a number of milestones in many thematic research areas including malaria public health, health systems, clinical research etc that have fed into policy change both locally and internationally.
Other members of the team who conducted the review were; Nick Rawlins, Chris Conlon, Sarah Bennet, Patrick Duffy, Simon Chaplin, Mike Turner, Mark Woolhouse, Menno De Jong among others.

Similar stories

UK National Health Service begins rollout of Oxford coronavirus vaccine

@Oxford General

The first patients are being vaccinated as part of the UK’s rollout of the Oxford / AstraZeneca coronavirus vaccine, ChAdOx1 nCoV-19, at the Oxford University NHS Hospitals Trust. The Oxford AstraZeneca vaccinations will be delivered at a small number of hospitals for the first few days for surveillance purposes, as is standard practice, before the bulk of supplies are sent to hundreds of GP-led services later in the week.

Receiving and responding to community feedback during health system crises in Kenya

KWTRP Publication Research

The responsiveness of a health system is one of its goals, alongside fairness in financing and outcomes. Listening and responding to the public can make a health system stronger and fairer. However, responsiveness is likely to be undermined, especially for vulnerable and marginal populations, in periods of crises such as disease outbreaks. In the current COVID-19 crisis, there has been more focus on health system control interventions, with minimal consideration of community views. KWTRP colleagues in Kenya consider community engagement and citizens feedback channels, concerns raised by the public and how they were handled, and highlight lessons learned.

Knowledge brokering platform launched to support health systems in the African region

KWTRP

The World Health Organization and partners including the KEMRI Wellcome Trust Research Programme launched AHOP (African Health Observatory Platform), an online platform to promote the exchange of evidence and experience across countries in the African region. By working to foster evidence-informed decision-making in an endeavor to re-engineer health service delivery, the initiative is expected to drive countries’ health system resilience efforts.

Trials of Oxford coronavirus vaccine begin in Kenya

KWTRP Research

Kenya has joined the global efforts in search of an effective vaccine for COVID-19 with the start of a trial evaluating the ChAdOx1 nCoV-2019 Oxford coronavirus vaccine. Following the necessary approvals from regulators, as well as the national ministry of health, and Kilifi county, the first volunteers for the trial have recently received their vaccinations.

Oxford Global Research

@Oxford General KWTRP MORU OUCRU

Oxford is world-famous for research excellence and home to some of the most talented people from across the globe. To showcase our global research, the University launched a Global Research Map, highlighting areas of research we are conducting overseas.

COVID-19: examining theories for Africa’s low death rates

@Oxford KWTRP

Africa accounts for 17% of the global population but only 3.5% of the reported global COVID-19 deaths. In many African countries, transmission has been higher but severity and mortality much lower than originally predicted based on experience in China and Europe. Kevin Marsh and Moses Alobo argue that Africa’s much younger population explains a very large part of the apparent difference. Some of the remaining gap is probably due to under reporting of events but there are a number of other plausible explanations, ranging from climatic differences, pre-existing immunity, genetic factors to behavioural differences.